SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Balance Sheet
Fiscal Year Start:
Oct 1
Assets in 2024 (Year End)
$24,263,903
Investments
59%
Cash & Equivalents
21%
Receivables (Non-Related)
10%
Property, Plant, & Equipment (net)
8%
Prepaid Expenses
1%
Inventories
<1%
Other Assets
<1%
Related-Party Receivables
0%
Liabilities in 2024 (Year End)
$5,341,760
Deferred Revenue
40%
Payables & Accruals
34%
Grants Payable
21%
Other Liabilities
4%
Notes Payable / Debt (Non-Related)
<1%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$7,382,757
$5,200,491
-30%
Receivables (Non-Related)
$2,211,363
$2,499,758
+13%
Related-Party Receivables
-
-
-
Inventories
$54,688
$61,661
+13%
Prepaid Expenses
$359,596
$307,511
-14%
Investments
$11,947,771
$14,320,832
+20%
Property, Plant, & Equipment (net)
$1,848,285
$1,846,998
0%
Other Assets
$4,950
$26,652
+438%
Total Assets
$23,809,410
$24,263,903
+2%
Liabilities
2023
2024
Change
Payables & Accruals
$2,924,169
$1,824,966
-38%
Grants Payable
$1,522,678
$1,144,600
-25%
Deferred Revenue
$2,383,673
$2,149,984
-10%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$11,877
$3,734
-69%
Related-Party Payables
-
-
-
Other Liabilities
$203,585
$218,476
+7%
Total Liabilities
$7,045,982
$5,341,760
-24%
Net assets
2023
2024
Change
Restricted Net Assets
$6,568,681
$5,708,525
-13%
Unrestricted Net Assets
$10,194,747
$13,213,618
+30%
Net assets
2023
2024
Change
Net assets
+$16,763,428
+$18,922,143
+13%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)